Synapse

← Lewis C. Cantley

Papers by Lewis C. Cantley

Page 4 · newest first

  1. Phosphoinositide 3-Kinase regulates glycolysis through mobilization of Aldolase A from the actin cytoskeletonCancer & Metabolism · 2014
  2. Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast CancerJournal of Clinical Oncology · 2014
  3. A Fundamental Trade-off in Covalent Switching and Its Circumvention by Enzyme Bifunctionality in Glucose HomeostasisJournal of Biological Chemistry · 2014
  4. Idelalisib — A PI3Kδ Inhibitor for B-Cell CancersNew England Journal of Medicine · 2014
  5. A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR InhibitionCancer Research · 2013
  6. What a Tangled Web We Weave: Emerging Resistance Mechanisms to Inhibition of the Phosphoinositide 3-Kinase PathwayCancer Discovery · 2013
  7. Targeting Metabolic Scavenging in Pancreatic CancerClinical Cancer Research · 2013
  8. Phenformin enhances the therapeutic benefit of BRAF V600E inhibition in melanomaProceedings of the National Academy of Sciences · 2013
  9. Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balanceCell Cycle · 2013
  10. Stem cell metabolism in tissue development and agingDevelopment · 2013
  11. Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1 -Mutant Lung CancerCancer Discovery · 2013
  12. Tyrosine Kinase BMX Phosphorylates Phosphotyrosine-Primed Motif Mediating the Activation of Multiple Receptor Tyrosine KinasesScience Signaling · 2013
  13. Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine MetabolismCancer Research · 2013
  14. Fetal Deficiency of Lin28 Programs Life-Long Aberrations in Growth and Glucose MetabolismStem Cells · 2013
  15. Protein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine PhosphorylationJournal of Biological Chemistry · 2013
  16. Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patientsProceedings of the National Academy of Sciences · 2013
  17. A Homogeneous, High-Throughput Assay for Phosphatidylinositol 5-Phosphate 4-Kinase with a Novel, Rapid Substrate PreparationPLoS ONE · 2013
  18. Somatic Mutations of PIK3R1 Promote GliomagenesisPLoS ONE · 2012
  19. Influence of Threonine Metabolism on S -Adenosylmethionine and Histone MethylationScience · 2012
  20. Pathological Role of Serum- and Glucocorticoid-Regulated Kinase 1 in Adverse Ventricular RemodelingCirculation · 2012
  21. AACR Cancer Progress Report 2012Clinical Cancer Research · 2012
  22. Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast CancerCancer Discovery · 2012
  23. Development of a High-Throughput Assay for Identifying Inhibitors of TBK1 and IKKεPLoS ONE · 2012
  24. IκB Kinase α Phosphorylation of TRAF4 Downregulates Innate Immune SignalingMolecular and Cellular Biology · 2012
  25. Metabolomics of Human Cerebrospinal Fluid Identifies Signatures of Malignant GliomaMolecular & Cellular Proteomics · 2012
  26. Genetic selection for enhanced serine metabolism in cancer developmentCell Cycle · 2011
  27. Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant ResponsesScience · 2011
  28. Exon-centric regulation of pyruvate kinase M alternative splicing via mutually exclusive exonsJournal of Molecular Cell Biology · 2011
  29. Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancersJournal of Clinical Investigation · 2011
  30. PHGDH amplification and altered glucose metabolism in human melanomaPigment Cell & Melanoma Research · 2011
  31. Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85α Src homology-2 domainsProceedings of the National Academy of Sciences · 2011
  32. Proteomic Screening Method for Phosphopeptide Motif Binding Proteins Using Peptide LibrariesJournal of Proteome Research · 2011
  33. The APL Paradigm and the “Co-Clinical Trial” ProjectCancer Discovery · 2011
  34. Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen‐activated protein Kinase (MAPK) and Phosphatidylinositol‐3‐kinase (PI3K)/AKT pathwaysJournal of Cellular Physiology · 2011
  35. TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, activity, localization and developmentBiochemical Journal · 2011
  36. Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin SignalingScience · 2011
  37. High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein StabilityCancer Discovery · 2011
  38. Characterization of KRAS Rearrangements in Metastatic Prostate CancerCancer Discovery · 2011
  39. AMP-Activated Protein Kinase Regulates Neuronal Polarization by Interfering with PI 3-Kinase LocalizationScience · 2011
  40. Ubiquitination of K-Ras Enhances Activation and Facilitates Binding to Select Downstream EffectorsScience Signaling · 2011
  41. Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutationsOpen Biology · 2011
  42. Metabolic Pathway Alterations that Support Cell ProliferationCold Spring Harbor Symposia on Quantitative Biology · 2011
  43. Rewiring of glycolysis in cancer cell metabolismCell Cycle · 2010
  44. Evidence for an alternative glycolytic pathway in rapidly proliferating cells2010
  45. Chemoprevention Meets Glucose ControlCancer Prevention Research · 2010
  46. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancerBritish Journal of Cancer · 2010
  47. Akt–RSK–S6 Kinase Signaling Networks Activated by Oncogenic Receptor Tyrosine KinasesScience Signaling · 2010
  48. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant miceProceedings of the National Academy of Sciences · 2010
  49. Altered metabolism in cancerBMC Biology · 2010
  50. The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor SignalingCancer Research · 2010